Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review

  • ID: 4432330
  • SWOT Analysis
  • 39 pages
  • GlobalData
  • Medigen Inc
1 of 5

FEATURED COMPANIES

  • DR. Chip Biotech Inc
  • PhytoHealth Corp
  • Vita Genomics Inc
  • MORE
Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. ’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Medigen Biotechnology Corp Key Recent Developments

Oct 19, 2017: MVC co-organized international forum for dengue prevention and vaccine development
Dec 09, 2016: MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease
Nov 23, 2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant
Nov 15, 2016: National Health Insurance (NHI) granted two Winston’s product with NHI drug price
Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • DR. Chip Biotech Inc
  • PhytoHealth Corp
  • Vita Genomics Inc
  • MORE
Section 1 - About the Company
  • Medigen Biotechnology Corp - Key Facts
  • Medigen Biotechnology Corp - Key Employees
  • Medigen Biotechnology Corp - Key Employee Biographies
  • Medigen Biotechnology Corp - Major Products and Services
  • Medigen Biotechnology Corp - History
  • Medigen Biotechnology Corp - Company Statement
  • Medigen Biotechnology Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Medigen Biotechnology Corp - Business Description
  • Medigen Biotechnology Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Medigen Biotechnology Corp - Strengths
  • Medigen Biotechnology Corp - Weaknesses
  • Medigen Biotechnology Corp - Opportunities
  • Medigen Biotechnology Corp - Threats
  • Medigen Biotechnology Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Medigen Biotechnology Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Oct 19, 2017: MVC co-organized international forum for dengue prevention and vaccine development
  • Dec 09, 2016: MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease
  • Nov 23, 2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant
  • Nov 15, 2016: National Health Insurance (NHI) granted two Winston’s product with NHI drug price
  • Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing
  • Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Medigen Biotechnology Corp, Key Facts
  • Medigen Biotechnology Corp, Key Employees
  • Medigen Biotechnology Corp, Key Employee Biographies
  • Medigen Biotechnology Corp, Major Products and Services
  • Medigen Biotechnology Corp, History
  • Medigen Biotechnology Corp, Other Locations
  • Medigen Biotechnology Corp, Subsidiaries
  • Medigen Biotechnology Corp, Key Competitors
  • Medigen Biotechnology Corp, Ratios based on current share price
  • Medigen Biotechnology Corp, Annual Ratios
  • Medigen Biotechnology Corp, Annual Ratios (Cont...1)
  • Medigen Biotechnology Corp, Annual Ratios (Cont...2)
  • Medigen Biotechnology Corp, Interim Ratios
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Medigen Biotechnology Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Medigen Biotechnology Corp, Performance Chart (2012 - 2016)
  • Medigen Biotechnology Corp, Ratio Charts
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vita Genomics Inc
  • Taiwan Liposome Company Ltd
  • PhytoHealth Corp
  • Lumosa Therapeutics Co Ltd
  • DR. Chip Biotech Inc
  • Development Center for Biotechnology
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll